ATE239700T1 - 24,24-difluorierte analogen von 1-alpha,25- dihydroxy vitamin d3 - Google Patents
24,24-difluorierte analogen von 1-alpha,25- dihydroxy vitamin d3Info
- Publication number
- ATE239700T1 ATE239700T1 AT99933481T AT99933481T ATE239700T1 AT E239700 T1 ATE239700 T1 AT E239700T1 AT 99933481 T AT99933481 T AT 99933481T AT 99933481 T AT99933481 T AT 99933481T AT E239700 T1 ATE239700 T1 AT E239700T1
- Authority
- AT
- Austria
- Prior art keywords
- alpha
- difluorinated
- ring
- analogues
- dihydroxy vitamin
- Prior art date
Links
- GMRQFYUYWCNGIN-NKMMMXOESA-N calcitriol Chemical class C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@@H](CCCC(C)(C)O)C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C GMRQFYUYWCNGIN-NKMMMXOESA-N 0.000 title abstract 2
- GMRQFYUYWCNGIN-UHFFFAOYSA-N 1,25-Dihydroxy-vitamin D3' Natural products C1CCC2(C)C(C(CCCC(C)(C)O)C)CCC2C1=CC=C1CC(O)CC(O)C1=C GMRQFYUYWCNGIN-UHFFFAOYSA-N 0.000 abstract 1
- -1 1-hydroxymethyl group Chemical group 0.000 abstract 1
- 102000004190 Enzymes Human genes 0.000 abstract 1
- 108090000790 Enzymes Proteins 0.000 abstract 1
- 230000001028 anti-proliverative effect Effects 0.000 abstract 1
- 230000000125 calcaemic effect Effects 0.000 abstract 1
- 235000020964 calcitriol Nutrition 0.000 abstract 1
- 239000011612 calcitriol Substances 0.000 abstract 1
- 230000015556 catabolic process Effects 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
- 230000003389 potentiating effect Effects 0.000 abstract 1
- 230000002103 transcriptional effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8803598P | 1998-06-03 | 1998-06-03 | |
| US09/323,106 US6043386A (en) | 1998-06-03 | 1999-06-01 | Non-calcemic, antiproliferative, transcriptionally active 24-fluorinated hybrid analogs of 1α,-25-dihydroxy vitamin D3 |
| PCT/US1999/012190 WO1999062876A1 (en) | 1998-06-03 | 1999-06-02 | 24,24-difluorinated analogs of 1-alpha,25-dihydroxy vitamin d3 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE239700T1 true ATE239700T1 (de) | 2003-05-15 |
Family
ID=26777918
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99933481T ATE239700T1 (de) | 1998-06-03 | 1999-06-02 | 24,24-difluorierte analogen von 1-alpha,25- dihydroxy vitamin d3 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US6043386A (de) |
| EP (1) | EP1095017B1 (de) |
| AT (1) | ATE239700T1 (de) |
| CA (1) | CA2334347C (de) |
| DE (2) | DE69907681T4 (de) |
| WO (1) | WO1999062876A1 (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000051554A2 (en) * | 1999-03-05 | 2000-09-08 | Johns Hopkins University | Regulating skin appearance and composition with a fluorinated vitamin d3 analog compound |
| ES2274785T3 (es) | 1999-04-01 | 2007-06-01 | Johns Hopkins University | Analogos de 1-alfa,25-dihidroxi vitamina d3 no calcemicos, antiproliferativos, transcripcionalmente activos que contienen azufre. |
| US20020137731A1 (en) | 2000-05-30 | 2002-09-26 | Gewirtz David A. | Combination of radiation and vitamin D3 analogs for the treatment of cancer |
| US20020041902A1 (en) * | 2000-09-29 | 2002-04-11 | Steiner Gregory Gene | Fluoride as a chemoprotective and chemotheraputic agent for cancer in mammals |
| US6559138B1 (en) * | 2001-09-21 | 2003-05-06 | Syntex (U.S.A.) Llc | 3-Desoxy-vitamin D3 analog esters |
| US20040258801A1 (en) * | 2001-09-27 | 2004-12-23 | Alvin Ling | Vitamin fortification of foodstuffs |
| US7101865B2 (en) * | 2002-06-13 | 2006-09-05 | Cytochroma Inc. | 24-sulfoximine vitamin D3 compounds |
| CA2510228C (en) * | 2002-12-18 | 2012-10-30 | Johns Hopkins University | 25-so2-substituted analogs of 1.alpha.,25-dihydroxyvitamin d3 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4421690A (en) * | 1982-05-17 | 1983-12-20 | Hoffmann-La Roche Inc. | Process for the preparation of 24,24-difluoro-1α,25-dihydroxy vitamin D3 and intermediates obtained therefrom |
| US4599330A (en) * | 1982-05-17 | 1986-07-08 | Hoffmann-La Roche Inc. | Method of treating milk fever |
| JPS6253960A (ja) * | 1985-05-30 | 1987-03-09 | Taisho Pharmaceut Co Ltd | ビタミンd↓3の誘導体 |
| US4853378A (en) * | 1986-10-20 | 1989-08-01 | Sumitomo Chemical Company, Limited | Fluorine derivatives of vitamin D3 and process for producing the same |
| US4970203A (en) * | 1988-12-09 | 1990-11-13 | Deluca Hector F | Method for improving reproductive functions in mammals |
| US5830885A (en) * | 1992-03-12 | 1998-11-03 | The Johns Hopkins University | Antiproliferative vitamin D3 hybrids |
| US5428029A (en) * | 1993-11-24 | 1995-06-27 | Hoffmann-La Roche Inc. | Vitamin D3 fluorinated analogs |
| JPH0873425A (ja) * | 1994-09-03 | 1996-03-19 | Nippon Oil & Fats Co Ltd | フッ素化ビタミンd誘導体および製造方法 |
-
1999
- 1999-06-01 US US09/323,106 patent/US6043386A/en not_active Expired - Lifetime
- 1999-06-02 DE DE69907681T patent/DE69907681T4/de not_active Expired - Lifetime
- 1999-06-02 WO PCT/US1999/012190 patent/WO1999062876A1/en not_active Ceased
- 1999-06-02 EP EP99933481A patent/EP1095017B1/de not_active Expired - Lifetime
- 1999-06-02 CA CA002334347A patent/CA2334347C/en not_active Expired - Fee Related
- 1999-06-02 AT AT99933481T patent/ATE239700T1/de not_active IP Right Cessation
- 1999-06-02 DE DE69907681A patent/DE69907681D1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| WO1999062876A1 (en) | 1999-12-09 |
| DE69907681T2 (de) | 2004-03-25 |
| EP1095017B1 (de) | 2003-05-07 |
| CA2334347C (en) | 2009-01-13 |
| DE69907681T4 (de) | 2007-04-12 |
| WO1999062876A8 (en) | 2000-09-14 |
| US6043386A (en) | 2000-03-28 |
| WO1999062876A9 (en) | 2000-10-26 |
| DE69907681D1 (de) | 2003-06-12 |
| EP1095017A1 (de) | 2001-05-02 |
| CA2334347A1 (en) | 1999-12-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1107548T1 (el) | 25-διυδροξυ βιταμινης d3 | |
| DE69907681D1 (de) | 24,24-difluorierte analogen von 1-alpha,25-dihydroxy vitamin d3 | |
| GT199900070A (es) | Derivados de isotiazol, utiles como agentes anticancerosos. | |
| ATE399151T1 (de) | 2-ethyl und 2-ethyliden-19-nor-vitamin d- verbindungen | |
| ES2088632T3 (es) | Base de goma de mascar ecologica. | |
| MX9301728A (es) | Conjunto conventidor para convertir un tractor de rueda de impulso en un tractor impulsado por pista | |
| CY1108988T1 (el) | Διαμορφωτες υποδοχεα βιταμινης d | |
| NZ314839A (en) | 1,25-Dihydroxy-16,23Z-diene-20-epi-16-ene-cholecalciferol (Vitamin D3) analogues | |
| DE69300196D1 (de) | 24-Cyclopropan-Vitamin-D-Derivate. | |
| BR9509739A (pt) | Compostos 18,19-dinor-vitamina d | |
| ATE165819T1 (de) | 26,28-methylen-1alpha,25-dihydroxy-vitamin-d2- verbindungen | |
| PT1069886E (pt) | Formulacoes topica do tipo oleo-em-agua compreendendo um material galactolipidico como emulsionante com um efeito prolongado de uma substancia activa incorporada | |
| Madeja et al. | The role of thioredoxin reductase activity in selenium-induced cytotoxicity | |
| WO1998051663A3 (en) | 3-epi compounds of vitamin d3 and uses thereof | |
| MXPA04011903A (es) | Moduladores de receptor de vitamina d tipo fenil-tiofeno. | |
| DE602004008505D1 (de) | Modulatoren des vitamin-d-rezeptors | |
| Fujishima et al. | Synthesis and biological activity of 2-methyl-20-epi analogues of 1α, 25-dihydroxyvitamin D3 | |
| WO2000051554A3 (en) | Regulating skin appearance and composition with a fluorinated vitamin d3 analog compound | |
| AR012598A1 (es) | Un analogo de vitamina d3 con dos cadenas laterales sobre el c-20, utilizaciones del mismo, un metodo para obtenerlo , un medicamento que contiene a dicho analogo y un compuesto util como intermedio para obtener dicho analogo | |
| IL104201A0 (en) | 26,27-dimethylene-1 alpha-25-dihydroxyvitamin d2 and its 24-epimer and pharmaceutical compositions containing them | |
| AR023546A1 (es) | Disulfuros ciclicos de pirrolidincarbonilamina | |
| BE901578A (fr) | Composition medicamenteuse pour le traitement ou la prevention de l'acne par administration orale. | |
| UY26473A1 (es) | Compuestos activos en el receptor de glucocorticoide | |
| IT1282733B1 (it) | Composizioni farmaceutiche contenenti ciclosporina ed un veicolante comprendente almeno un estere dell'acido alfa-glicerofosforico | |
| ES2038663T3 (es) | Un metodo para preparar una composicion para la aplicacion por via topica, destinada al tratamiento de la enfermedad epitelial hiperproliferativa. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |